Clinical Study

Apollo

Posted Date: Jul 22, 2019

  • Investigator: Bassam Abu Jawdeh
  • Specialties: Nephrology, Transplant Nephrology
  • Type of Study: Observational/Survey

The National Institutes of Health (NIH)-sponsored collaborative APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) is charged with prospectively assessing the effects of renal-risk variants (RRVs) in the apolipoprotein L1 gene (APOL1) on outcomes for kidneys from donors with recent African ancestry and the recipients of their kidneys, after deceased- and living-donor renal transplantation. For the purposes of APOLLO, recent African ancestry is defined as individuals with similar genetic make-up to those currently residing in Africa. APOLLO will also study the impact of APOL1 RRVs on the health of living kidney donors with recent African ancestry.

Criteria:

Living Kidney Donors With Self Reported Recent African Ancestry. Recipients Of A Kidney Transplant From An Eligible Living Or Deceased Donor With Recent African Ancestry.

Keywords:

Apol1

For More Information:

Kathleen Harrison
513-558-1880
harri3kh@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.